Daniel C. Martin Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

Daniel C. Martin is Chief Commercial Officer of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2024, when has been sold 31,330 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Daniel C. Martin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	31,330 Reduced 100.0%	0 Common Stock
Jun 11 2024	SELL Sale (or disposition) back to the issuer	-	43,951 Reduced 58.38%	31,330 Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	-	20,163 Added 21.13%	75,281 Common Stock
Feb 16 2024	SELL Open market or private sale	$35,410 $15.62 p/Share	2,267 Reduced 3.95%	55,118 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	9,725 Added 14.49%	57,385 Common Stock
Jan 16 2024	SELL Open market or private sale	$23,499 $14.47 p/Share	1,624 Reduced 3.3%	47,660 Common Stock
Dec 13 2023	SELL Open market or private sale	$26,543 $15.37 p/Share	1,727 Reduced 3.39%	49,284 Common Stock
Dec 12 2023	BUY Grant, award, or other acquisition	-	5,576 Added 9.85%	51,011 Common Stock
Nov 30 2023	SELL Open market or private sale	$223,758 $12.57 p/Share	17,801 Reduced 28.15%	45,435 Common Stock
Oct 30 2023	SELL Open market or private sale	$16,912 $12.02 p/Share	1,407 Reduced 2.19%	62,884 Common Stock
Oct 28 2023	BUY Grant, award, or other acquisition	-	5,576 Added 7.98%	64,291 Common Stock
Jun 16 2023	SELL Open market or private sale	$17,827 $14.4 p/Share	1,238 Reduced 2.08%	58,413 Common Stock
Feb 16 2023	SELL Open market or private sale	$17,500 $15.1 p/Share	1,159 Reduced 1.95%	58,381 Common Stock
Feb 15 2023	BUY Grant, award, or other acquisition	-	11,151 Added 15.77%	59,540 Common Stock
Jan 17 2023	SELL Open market or private sale	$34,047 $21.24 p/Share	1,603 Reduced 3.21%	48,389 Common Stock
Jun 16 2022	SELL Open market or private sale	$14,093 $10.75 p/Share	1,311 Reduced 2.58%	49,521 Common Stock
Feb 16 2022	SELL Open market or private sale	$10,371 $9.05 p/Share	1,146 Reduced 2.3%	48,668 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	13,667 Added 21.53%	49,814 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	8,300 Added 18.67%	36,147 Common Stock

DCM

Daniel C. Martin

Chief Commercial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Value

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH

Account